Industry growth is driven by demand for cost-effective generics and emerging market access Paclitaxel Injection Market Paclitaxel Injection Market Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The ...

Eli Lilly on Wednesday became the second company to gain approval for a weight-loss pill, as the multibillion-dollar market ...

April 1 () - Eli Lilly on Wednesday became the second company to gain approval for a weight-loss pill, as the ...

The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli ...

Pfizer held a close to 12% stake in ViiV Healthcare, a London-based pharmaceutical venture specialising in HIV and AIDS ...

April 1 (Reuters) - The weight-loss drug market is surging, with biotech firms racing to corner a share in a sector dominated by Novo Nordisk and Eli Lilly. Analysts forecast the industry will ...

Colorado drugmaker Ambrosia Biosciences has landed $100 million to pursue an oral obesity drug it’s hoping can compete with a ...

Key opportunities include rising demand due to global cancer prevalence, expansion in emerging markets, and advancements in ...

Addressing pressing questions about upcoming ATTR-CM competition and market opportunity, Alnylam management on Tuesday ...

Lotte Bjerre Knudsen played a pivotal role in developing Ozempic and Wegovy. Now she wants to develop a once-a-year injection ...

The Japanese health ministry is set to begin regular vaccinations for respiratory syncytial virus, or RSV, which can cause pneumonia in infants, on Wednesday, the start of fiscal 2026. Infants in Japa ...

The vaccine will be administered to women in their 28th to 36th weeks of pregnancy to immunize their babies, with costs primarily covered by public funds.